-
Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial
09 Sep 2025 12:45 GMT
… A of the trial to receive high dose cytarabine (HiDAC) … and Orphan Drug Designation from the FDA for the treatment of … Biotech, Inc. Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical … to conduct its clinical trials as described in this …
-
Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
08 Sep 2025 12:30 GMT
… A of the trial to receive high dose cytarabine (HiDAC) … and Orphan Drug Designation from the FDA for the treatment of … Biotech, Inc. Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical … to conduct its clinical trials as described in this …
-
Outlining Historical Standards for Treatment in Newly Diagnosed CML
06 Sep 2025 00:09 GMT
… of care prior to the FDA approval of imantinib (Gleevac … inhibitors (TKIs) for the treatment of this patient population.
Toxicities … combined with low doses of cytarabine, and the other was … for Drug Evaluation and Research: Application Number: NDA 21-335. FDA. …
-
The Role of The Xihuang Pill in Inhibiting Triple-Negative Breast Cancer Through Immunogenic Cell Death
05 Sep 2025 13:47 GMT
… development of this medicine.Keywords: Xihuang pill, triple-negative … kinds of conjugate cytarabine and bile acids, … improve dendritic cell-based vaccines for lymphoma immunotherapy. … its cellular localisation following drug treatment. Cell Stress Chaperones. …
-
How Philadelphia scientists turn toxic fungi, snake venom, and trees into medicine
03 Sep 2025 17:08 GMT
… popular prescription drugs.
Scientists would often find these medicines through trial-and-error … as effective as two FDA-approved leukemia drugs, cytarabine and daunorubicin, according to …
-
Natural Products From Traditional Chinese Medicine: Potential Therapeutic Agents in Cancer Therapy-Induced Cardiotoxicity
02 Sep 2025 16:45 GMT
… progress of modern medicine and biotechnology, the research … pharmaceuticals or possible therapeutic targets for CTIC treatment … . Furthermore, randomized trials and meta-analyses … drugs (5-fluorouracil, 6-mercaptopurine, A2O3, taxanes, cytarabine, …
-
Annamycin Plus Cytarabine Drive Potential OS Benefit in Acute Myeloid Leukemia
29 Aug 2025 00:02 GMT
… MB-106 trial (NCT06788756) announced by Moleculin Biotech.1
Findings … are better than any drug ever approved for second- … weeks of the first study drug. Other key inclusion criteria … annamycin in combination with cytarabine for the treatment of subjects with …
-
Relapsed/Refractory Acute Myeloid Leukemia Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, And Companies
23 Aug 2025 02:47 GMT
… , Kronos Bio, Maxinovel Pharmaceuticals, AB Science, CicloMed, … insights into clinical trials, emerging therapies, … Acute Myeloid Leukemia Treatment Drugs
Relapsed/Refractory … Pipeline Therapies- APG-2575, Cytarabine, Venetoclax, Tagraxofusp, Cladribine …
-
Injectable Cytotoxic Drugs Market: Future Demand and Top Key Players Analysis | 2029
21 Aug 2025 13:19 GMT
… of combination chemotherapy treatments, increased spending in … of biosimilar cytotoxic medications, an increased emphasis … cancer drug discovery, and partnerships among pharmaceutical corporations. … -Fluorouracil (5-FU), Cytarabine, Gemcitabine
3) By …
-
Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14 Aug 2025 13:15 GMT
… Biotech, Inc. Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical … AnnAraC Clinical Evaluation) Trial (MB-108), a pivotal, … cytarabine, together referred to as AnnAraC, for the treatment … feedback from the FDA and their foreign equivalents. …